ResMed Inc. vs. Treace Medical Concepts, Inc. Common Stock
ResMed Inc. (RMD) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| RMD | TMCI | |
|---|---|---|
| Market Cap | $33.40 billion | $282.25 million |
| Revenue (TTM) | $5.65 billion | $205.31 million |
| Net Income (TTM) | $1.52 billion | $-59,516,000 |
RMD leads on 3 of 3 size & scale factors.
Valuation
| RMD | TMCI | |
|---|---|---|
| P/E Ratio | 22.29 | — |
| Price / Book | 5.07 | 4.17 |
| Price / Sales | 5.91 | 1.37 |
TMCI leads on 2 of 2 valuation factors.
Profitability
| RMD | TMCI | |
|---|---|---|
| Net Margin | 26.94% | -28.99% |
| Return on Equity | 23.13% | -87.86% |
RMD leads on 2 of 2 profitability factors.
Dividend
| RMD | TMCI | |
|---|---|---|
| Dividend Yield | 1.14% | — |
| Payout Ratio | 25.31 | — |
RMD and TMCI split the dividend factors evenly.
Risk & Sentiment
| RMD | TMCI | |
|---|---|---|
| Short Interest | 4.04% | 0.08% |
TMCI leads on 1 of 1 risk & sentiment factors.
Dig deeper: RMD overview, RMD financials, TMCI overview, TMCI financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.